Showing results (2421-2430 of 3,662) with videos related to
Sort By:
Pageof 367
Breast (Edinburgh, Scotland)|September 25, 2020
NT-proBNP as predictor factor of cardiotoxicity during trastuzumab treatment in breast cancer patientsIsabel Blancas, Francisco J Martín-Pérez, José M Garrido, et al.Breast (Edinburgh, Scotland)|January 17, 2020
Second conservative treatment for second ipsilateral breast tumor event: A systematic review of the different re-irradiation techniquesLucile Montagne, Arthur Hannoun, Jean-Michel Hannoun-LeviBreast (Edinburgh, Scotland)|December 8, 2019
What do patients and health care professionals view as important attributes in radiotherapy decisions? Input for a breast cancer patient decision aidD B Raphael, J A Ter Stege, N S Russell, et al.Breast (Edinburgh, Scotland)|December 9, 2019
Adjuvant regional nodal irradiation did not improve outcomes in T1-2N1 breast cancer after breast-conserving surgery: A propensity score matching analysis of BIG02/98 and BCIRG005 trialsWei-Xiang Qi, Lu Cao, Cheng Xu, et al.Breast (Edinburgh, Scotland)|December 23, 2019
"Randomised controlled trial of scalp cooling for the prevention of chemotherapy induced alopecia"J Bajpai, S Kagwade, A Chandrasekharan, et al.Breast (Edinburgh, Scotland)|January 6, 2020
Comparison of the efficacy of cryotherapy and compression therapy for preventing nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: A prospective self-controlled trialYuko Kanbayashi, Koichi Sakaguchi, Takeshi Ishikawa, et al.Breast (Edinburgh, Scotland)|August 29, 2020
Clinical application of axillary reverse mapping in patients with breast cancer: A systematic review and meta-analysisWilson A Wijaya, Jing Peng, Yinhai He, et al.Breast (Edinburgh, Scotland)|August 29, 2020
Quality and reporting of clinical guidelines for breast cancer treatment: A systematic reviewMarta Maes-Carballo, Luciano Mignini, Manuel Martín-Díaz, et al.Breast (Edinburgh, Scotland)|April 7, 2020
What are the appropriate thresholds for High Quality Performance Indicators for breast surgery in Australia and New Zealand?Shehnarz Salindera, Michelle Ogilvy, Andrew SpillaneBreast (Edinburgh, Scotland)|October 23, 2020
Safety and efficacy of cyclin-dependent kinase inhibitor rechallenge following ribociclib-induced limiting hypertransaminasemiaJesús Fuentes-Antrás, Alicia de Luna, Alfonso López de Sá, et al.Pageof 367